Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 2, 2004, Pages 157-167

  Kariyazono, Hiroko ^a   Nakamura, Kazuo ^a   Arima, Junko ^a   Ayukawa, Osamu ^a   Onimaru, Shunji ^a   Masuda, Hiroshi ^a   Iguro, Yoshifumi ^a   Majima, Hideyuki J ^a   Sakata, Ryuzo ^a   Yamada, Katsushi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Aspirin; Cilostazol; Platelet rich plasma; Ramatroban; Whole blood aggregation

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CILOSTAZOL; COLLAGEN; PADGEM PROTEIN; RAMATROBAN; THROMBOXANE A2; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BLOOD CLOTTING; CELL INTERACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; LEUKOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; ASPIRIN; CARBAZOLES; COLLAGEN; CYCLOOXYGENASE INHIBITORS; HUMANS; MICROSCOPY, CONFOCAL; PHOSPHODIESTERASE INHIBITORS; PLASMA; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; REPRODUCIBILITY OF RESULTS; SULFONAMIDES; TETRAZOLES;

EID: 12144291657     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200403000-00007     Document Type: Article

References (35)

1. Ross R. Mechanisms of disease: atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:115-126.
2. Hollenberg NK, Monterio K, Sandoz T. Endothelial injury provokes collateral arterial spasm: role of thromboxane and serotonin. J Pharmacol Exp Therap 1988; 244:1164-1168.
3. Rand ML, Leung R, Packham MA. Platelet function assays. Transfusion Apheresis Sci 2003; 28:307-317.
4. Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, Kume S. Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 1994; 218:284-294.
5. Yang L, Yatomi Y, Satoh K, Ozaki Y. Inhibitory effects of beraprost on platelet aggregation: comparative study utilizing two methods of aggregometry. Thromb Res 1999; 94:25-32.
6. Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980; 3:147-154.
7. Ingerman-Wojenski C, Smith JB, Silver MJ. Evaluation of electrical aggregometry: comparison with optical aggregometry, secretion of ATP, and accumulation of radiolabeled platelets. J Lab Clin Med 1983; 101:44-52.
8. Fattorutto M, Pradier O, Schmartz D, Ickx B, Barvais L. Does the platelet function analyser (PFA-100®) predict blood loss after cardiopulmonary bypass? Br J Anaesth 2003; 90:692-693.
9. Smith JW, Steinhubl SR, Lincoff AM, Coleman JC, Lee TT, Hillman RS, et al. Rapid platelet-function assay: an automated and quantitative cartridge-based method. Circulation 1999; 99:620-625.
10. Malinin AI, Atar A, Callahan KP, McKenzie ME, Serebruany VL. Effects of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease. Eur J Pharmacol 2003; 462:139-143.
11. Swank RL. Alteration of blood on storage: measurement of adhesiveness of 'aging' platelets and leukocytes and their removal by filtration. N Engl J Med 1961; 265:728-733.
12. Dhall DP, Matheson NA. Platelet aggregate filtration pressure - a method of measuring platelet aggregation in whole blood. Cardiovasc Res 1969; 3:155-160.
13. Faraday N, Scharpf RB, Dodd-o JM, Martinez BA, Rosenfeld BA, Dorman T. Leukocytes can enhance platelet-mediated aggregation and thromboxane release via interaction of P-selectin glycoprotein ligand 1 with P-selectin. Anesthesiology 2001; 94:145-151.
14. Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest 1991; 87:571-580.
15. Ozeki Y, Sudo T, Toga K, Nagamura Y, Ito H, Ogawa T, et al. Characterization of whole blood aggregation with a new type of aggregometer by a screen filtration pressure method. Thromb Res 2001; 101:65-72.
16. Sudo T, Ito H, Ozeki Y, Kimura M. Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration method. Br J Pharmacol 2001; 133:1396-1404.
17. Sudo T, Ito H, Kimura M. Characterization of platelet aggregation in whole blood of laboratory animals by a screen filtration pressure method. Platelets 2003; 14:239-246.
18. Nakamura K, Kariyazono H, Moriyama Y, Toyohira H, Kubo H, Yotsumoto G, et al. Effects of sarpogrelate hydrochloride on platelet aggregation, and its relation to the release of serotonin and P-selectin. Blood Coagul Fibrinolysis 1999; 10:513-519.
19. Kariyazono H, Nakamura K, Shinkawa T, Yamaguchi T, Sakata R, Yamada K. Inhibition of platelet aggregation and the release of P-selectin from platelets by cilostazol. Thromb Res 2001; 101:445-453.
20. Moriyama Y, Nakamura K, Kariyazono H, Toyohira H, Taira A. Influence of low-intensity anticoagulation and low-dose antiplatelet agent on coagulation-fiblinolysis system after mechanical prosthetic valve replacement. J Thorac Cardiovas Surg 1998; 115:952-954.
21. Nakamura K, Kariyazono H, Masuda H, Sakata R, Yamada K. Effects of sarpogrelate hydrochloride on adenosine diphosphate-or collagen-induced platelet responses in arteriosclerosis obliterans. Blood Coagul Fibrinolysis 2001; 12:391-397.
22. Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity of fibroblasts and smooth muscle cell is due to PDGF-AA. Science 1989; 243:393-396.
23. Okazaki H, Majesky MW, Harker LA, Schwartz SM. Regulation of platelet-derived growth factor ligand and gene expression by α-thrombin in vascular smooth muscle cell. Circ Res 1992; 71:1285-1293.
24. Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC. Release and activation of platelet latent TGF-β in blood clots during dissolution with plasmin. Nat Med 1995; 1:932-937.
25. Johnston GI, Cook RG, McEver RP. Cloning of GMP-140, a granule membrane protein, of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation. Cell 1989; 56:1033-1044.
26. McEver RP, Martin BR. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 1984; 259: 9799-9804.
27. 2-receptor antagonists on platelet function in vitro. Hum Exp Toxicol 1999; 18:487-492.
28. Kariyazono H, Nakamura K, Shinkawa T, Moriyama Y, Toyohira H, Taira A, et al. Inhibitory effects of antibiotics on platelet aggregation in vitro. Hum Exp Toxicol 1997; 16:662-666.
29. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194:927-929.
30. Motoori S, Majima HJ, Ebara M, Kato H, Hirai F, Kakinuma S, et al. Overexpression of mitochondrial manganese superoxide dismutase protects against radiation-induced cell death in the human hepatocellular carcinoma cell line HLE. Cancer Res 2001; 61:5382-5388.
31. Majima HJ, Nakanishi-Ueda T, Ozawa T. 4-Hydroxy-2-nonenal (5-NHE) staining by Anti-HNE antibody. In: Armstrong D (editor): Oxidants and antioxidants: ultrastructure and molecular biology protocols. Totowa, New Jersey: Humana Press, 2002; pp. 31-34.
32. Geiger J, Honig-Liedl P, Schanzenbacher P, Walter U. Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors. Eur J Pharmacol 1998; 351:235-246.
33. 1. Blood 1997; 89:1235-1242.
34. 2 generation. J Biol Chem 1998; 273:4338-4344.
35. 2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems. J Biol Chem 1990; 265:6836-6844.